Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Head and Neck Neoplasms 4Squamous Cell Carcinoma of Head and Neck 2Sarcoma 2Radiation Injuries 2Ovarian Neoplasms 2Drug-Related Side Effects and Adverse Reactions 2Brain Neoplasms 2Xerostomia 1Wilms Tumor 1Uterine Cervical Neoplasms 1Testicular Neoplasms 1Teratoma 1Sarcoma, Ewing 1Salivary Gland Neoplasms 1Rhabdomyosarcoma 1Retinoblastoma 1Ovarian Germ Cell Cancer 1Oropharyngeal Neoplasms 1Neurotoxicity Syndromes 1Neuroectodermal Tumors 1Neuroblastoma 1Neoplasms, Plasma Cell 1Nasopharyngeal Neoplasms 1Multiple Myeloma 1Mucositis 1Mouth Neoplasms 1Medulloblastoma 1Liver Neoplasms 1Laryngeal Neoplasms 1Kidney Neoplasms 1

Interventions

motexafin gadolinium 1antineoplaston AS 2-1 1antineoplaston A10 1Surgical Procedures, Operative 1Radiotherapy 1Immunohistochemistry 1Fluorouracil 1Fluorescent Antibody Technique 1Flow Cytometry 1Electroacupuncture 1Doxepin 1Cisplatin 1Celecoxib 1Biopsy 1Amifostine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Hypopharyngeal Neoplasms × Amifostine × Clear all
NCT00003777 2022-01-26

Surgery, Radiation Therapy, and Combination Chemotherapy in Treating Patients With Recurrent Head and Neck Cancer

Abramson Cancer Center at Penn Medicine

Phase 2 Terminated
35 enrolled
Head & Neck

Head and Neck Neoplasms, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Oropharyngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡